Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu

Immunology. 2009 Mar;126(3):436-45. doi: 10.1111/j.1365-2567.2008.02911.x. Epub 2008 Sep 1.

Abstract

Human leucocyte antigen G (HLA-G) is a tolerogenic molecule that protects the fetus from maternal immune attack, may favour tumoral immunoescape and is up-regulated in viral and inflammatory diseases. The aim of this work was to discover if nitric oxide (NO) could affect HLA-G expression or function because NO is an important modulator of innate and adaptive immunity. For this purpose HLA-G expression and function were analysed following treatment with a NO donor or a peroxynitrite donor in various cell lines expressing HLA-G either spontaneously or upon transfection. Results showed NO-dependent nitration of both cellular and soluble HLA-G protein, but not all HLA-G moieties underwent nitration. Endogenous biosynthesis of NO by both U-937-HLA-G1 and M8-HLA-G5 stable transfectants also caused HLA-G nitration. The NO decreased total HLA-G cellular protein content and expression on the cell surface, while increasing HLA-G shedding into the culture medium. This effect was post-transcriptional and the result of metalloprotease activity. By contrast, NO pretreatment did not affect HLA-G capability to suppress NK cytotoxicity and lymphocyte proliferation. Our studies show that NO regulates the availability of HLA-G molecules without modifying their biological activities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytotoxicity, Immunologic
  • Dose-Response Relationship, Immunologic
  • HLA Antigens / drug effects
  • HLA Antigens / metabolism*
  • HLA-G Antigens
  • Histocompatibility Antigens Class I / drug effects
  • Histocompatibility Antigens Class I / metabolism*
  • Humans
  • Immune Tolerance / immunology*
  • Killer Cells, Natural / immunology
  • Matrix Metalloproteinases / immunology*
  • Molsidomine / analogs & derivatives
  • Molsidomine / pharmacology
  • Nitric Oxide / immunology*
  • Nitric Oxide Donors / pharmacology
  • RNA Processing, Post-Transcriptional / immunology
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Triazenes / pharmacology
  • Tumor Cells, Cultured

Substances

  • 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene
  • HLA Antigens
  • HLA-G Antigens
  • Histocompatibility Antigens Class I
  • Nitric Oxide Donors
  • Triazenes
  • Nitric Oxide
  • linsidomine
  • Molsidomine
  • Matrix Metalloproteinases